Physician profile
Jasser Thiara
NPI 1053562009
$2,414.30
in general payments reported to CMS, 2019-2025
24 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $381 · 2020: $148 · 2021: $606 · 2022: $660 · 2023: $529 · 2024: $90.52.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $619.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $521.14 | 2019-2023 | Lo Loestrin Fe |
| Mayne Pharma Commercial LLC | $258.62 | 2021-2024 | |
| Hologic Sales and Service, LLC | $244.78 | 2021-2023 | Aptima |
| Coopersurgical, INC. | $211.68 | 2020-2023 | Summit Doppler, Wallach Cryosurgical Equipment |
| Aspira Women'S Health INC | $151.28 | 2022-2023 | Ova1 |
| Avanos Medical | $140.29 | 2021 | |
| Stryker Corporation | $125.33 | 2021 | |
| Dexcom, INC. | $100.65 | 2023 | Dexcom G7 Gss (161) |
| Myovant Sciences INC. | $96.26 | 2021-2022 | |
| Dysis Medical, INC. | $73.27 | 2021-2022 | |
| Avion Pharmaceuticals | $65.73 | 2020-2023 | Balcoltra |
| Allergan, INC. | $56.24 | 2019-2020 | |
| Myriad Women'S Health, INC. | $52.53 | 2023 | |
| Integra Lifesciences Corporation | $48.31 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Sumitomo Pharma America, INC. | $47.21 | 2023 | Myfembree |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Roche Diagnostics Corporation | $43.49 | 2019-2021 | |
| Fujifilm New Development USA, INC. | $26.26 | 2019 | |
| Astellas Pharma US INC | $25.16 | 2023 | Veozah |
| Evofem Biosciences, INC. | $24.63 | 2021 | |
| Acessa Health INC. | $24.62 | 2021 | |
| Duchesnay USA Incorporated | $21.75 | 2019 | |
| Amag Pharmaceuticals, INC. | $20.04 | 2020 | |
| Exeltis, USA INC. | $19.14 | 2023 | Slynd |
| Therapeuticsmd, INC. | $15.89 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jasser Thiara listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.